ArticleDermatology and therapy2022

Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas' Psoriasis Registry.

Jessica A Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.